US Department of Health and Human Services allows sale of 6 unapproved peptide formulations at compounding pharmacies
HHS Harte-Hanks Inc
$4.01 -0.50%
View chart & analysis → - 1The Department of Health and Human Services will allow compounding pharmacies to manufacture and sell 6 types of peptides starting October 29, 2026.
- 2The decision to expand peptide access was made following an 8-6 vote by the committee in July 2026.
- 3Robert F. Kennedy Jr. pressured for a re-examination of several peptides that the FDA had restricted in 2023.
So what's the key point?
The US Department of Health and Human Services has permitted pharmacies to prepare and sell 6 types of peptide medicines. This change makes these medicines easier to obtain following pressure from Robert F. Kennedy Jr.
Source Fortune · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.